Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does gamma-hydroxybutyrate inhibit or stimulate central DA release?

J J Feigenbaum1, S G Howard

  • 1Department of Research and Development, American Institute of Biotechnology, Elk Grove Village, IL 60007, USA.

The International Journal of Neuroscience
|November 1, 1996
PubMed
Summary

Gamma-hydroxybutyrate (GHB) primarily inhibits dopamine release, contrary to recent suggestions. This finding clarifies GHB's role as a research tool by confirming its inhibitory effect on central dopamine pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial inequality in the annual risk of Tuberculosis infection in the United States, 1910-1933.

Epidemiology and infection·2017
Same author

Environmental pollutants and beta cell function: relevance for type 1 and gestational diabetes.

Diabetologia·2011
Same author

Identification of the dopamine D3 receptor in oligodendrocyte precursors: potential role in regulating differentiation and myelin formation.

The Journal of neuroscience : the official journal of the Society for Neuroscience·1998
Same author

Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis study.

Neuroscience letters·1997
Same author

On the synthesis of neurotransmitter receptor agonists with antagonist potential.

Neurochemical research·1997
Same author

Effect of gamma-hydroxybutyrate on central dopamine release in vivo. A microdialysis study in awake and anesthetized animals.

Biochemical pharmacology·1997

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Gamma-hydroxybutyrate (GHB) is a widely used research tool due to its effects on dopamine release.
  • Recent studies suggest GHB stimulates dopamine release, contradicting earlier findings of inhibition.

Purpose of the Study:

  • To critically review literature and determine if GHB inhibits or stimulates central dopamine release.
  • To clarify the discrepancies in previous research findings regarding GHB's effect on dopamine.

Main Methods:

  • Critical literature review of studies investigating GHB's effect on dopamine release.
  • Analysis of methodological factors in studies reporting conflicting results.

Main Results:

  • The literature review suggests GHB inhibits presynaptic dopamine release.

Related Experiment Videos

  • Recent studies showing stimulation were conducted under anesthesia or high calcium, which can spuriously enhance dopamine release.

    • Conclusions:

    • GHB's primary effect is the inhibition of dopamine release, consistent with its known behavioral and pharmacological activities.
    • Anesthesia and high calcium concentrations in experimental conditions may explain conflicting results in recent studies.